BRCA1 and ovarian carcinoma: Significant differences were found in risk accuracy for three of the eight items; the DA group made significantly more accurate risk estimates for BRCA1/2 related ovarian cancer risk, and cure of BRCA1/2 related breast cancer diagnosed during screening and cure of BRCA1/2 related ovarian cancer diagnosed during screening.